Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fojo

Showing results (111-120 of 180) with videos related to

Pageof 18
Sort By:
Cancer|May 10, 2012
Interleukin-13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinomaMeenu Jain, Lisa Zhang, Mei He, et al.
The Lancet. Public Health|October 31, 2017
Current and future trends in tuberculosis incidence in New York City: a dynamic modelling analysisAnthony T Fojo, Natalie L Stennis, Andrew S Azman, et al.
Blood|September 1, 1989
Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemiaM L Rothenberg, L A Mickley, D E Cole, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Molecular targets in the National Cancer Institute drug screenS E Bates, A T Fojo, J N Weinstein, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1991
Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomasS E Bates, C Y Shieh, L A Mickley, et al.
The Journal of Biological Chemistry|October 25, 1989
Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agentsL A Mickley, S E Bates, N D Richert, et al.
JAMA Oncology|December 6, 2019
Immune Status and Associated Mortality After Cancer Treatment Among Individuals With HIV in the Antiretroviral Therapy EraKeri L Calkins, Geetanjali Chander, Corinne E Joshu, et al.
AIDS Research and Human Retroviruses|November 5, 2019
Short Communication: Differences in 5-Year Survival After Cancer Diagnosis Between HIV Clinic Enrollees and the General U.S. PopulationKeri L Calkins, Geetanjali Chander, Corinne E Joshu, et al.
Cancer Causes & Control : CCC|March 8, 2020
A comparison of cancer stage at diagnosis and treatment initiation between enrollees in an urban HIV clinic and SEERKeri L Calkins, Geetanjali Chander, Corinne E Joshu, et al.
Cancer Research|December 22, 1999
Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cellsM Brangi, T Litman, M Ciotti, et al.
Pageof 18

Showing results (111-120 of 180) with videos related to

Sort By:
Pageof 18
Cancer|May 10, 2012
Interleukin-13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinomaMeenu Jain, Lisa Zhang, Mei He, et al.
The Lancet. Public Health|October 31, 2017
Current and future trends in tuberculosis incidence in New York City: a dynamic modelling analysisAnthony T Fojo, Natalie L Stennis, Andrew S Azman, et al.
Blood|September 1, 1989
Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemiaM L Rothenberg, L A Mickley, D E Cole, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Molecular targets in the National Cancer Institute drug screenS E Bates, A T Fojo, J N Weinstein, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1991
Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomasS E Bates, C Y Shieh, L A Mickley, et al.
The Journal of Biological Chemistry|October 25, 1989
Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agentsL A Mickley, S E Bates, N D Richert, et al.
JAMA Oncology|December 6, 2019
Immune Status and Associated Mortality After Cancer Treatment Among Individuals With HIV in the Antiretroviral Therapy EraKeri L Calkins, Geetanjali Chander, Corinne E Joshu, et al.
AIDS Research and Human Retroviruses|November 5, 2019
Short Communication: Differences in 5-Year Survival After Cancer Diagnosis Between HIV Clinic Enrollees and the General U.S. PopulationKeri L Calkins, Geetanjali Chander, Corinne E Joshu, et al.
Cancer Causes & Control : CCC|March 8, 2020
A comparison of cancer stage at diagnosis and treatment initiation between enrollees in an urban HIV clinic and SEERKeri L Calkins, Geetanjali Chander, Corinne E Joshu, et al.
Cancer Research|December 22, 1999
Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cellsM Brangi, T Litman, M Ciotti, et al.
Pageof 18